Clinical Aspects of Drug–Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K)-Reference-Cited by-同舟云学术

Clinical Aspects of Drug–Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K)

Published:2022-04-01 Issue:4 Volume:45 Page:382-393
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Saad Abdulaziz Ahmed A.¹,Zhang Fan²,Mohammed Eyad Abdulwhab H.¹,Wu Xin’an²

Affiliation:

1. School of Pharmacy, Lanzhou University

2. Department of Pharmacy, the First Hospital of Lanzhou University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/45/4/45_b21-00916/_pdf

Reference106 articles.

1. 1) Neuhoff S, Ungell AL, Zamora I, Artursson P. pH-Dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions. Pharm. Res., 20, 1141–1148 (2003).

2. 2) Koepsell H. Organic cation transporters in health and disease. Pharmacol. Rev., 72, 253–319 (2020).

3. 3) Sandoval PJ, Zorn KM, Clark AM, Ekins S, Wright SH. Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates. Mol. Pharmacol., 94, 1057–1068 (2018).

4. 4) Li M, Anderson GD, Wang J. Drug-drug interactions involving membrane transporters in the human kidney. Expert Opin. Drug Metab. Toxicol., 2, 505–532 (2006).

5. 5) Morrissey KM, Stocker SL, Wittwer MB, Xu L, Giacomini KM. Renal transporters in drug development. Annu. Rev. Pharmacol. Toxicol., 53, 503–529 (2013).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The toxicity of cisplatin derives from effects on renal organic ion transporters expression and serum endogenous substance levels;Food and Chemical Toxicology;2024-10

2. Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective;Clinical Pharmacokinetics;2024-06

3. Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen;BMC Cancer;2024-04-02

4. Transcriptomic analysis and oxidative stress induced by sodium dichloroisocyanurate in the intestine of Phascolosoma esculenta;Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology;2024-04

5. Pentafluorosulfanyl-substituted biaryl derivatives as MATE-type transporter inhibitors targeting drug-resistant bacteria;Bioorganic & Medicinal Chemistry;2024-02